Fig. 5
From: Role of PET/CT in post-therapeutic assessment of bronchogenic carcinoma
a–d Axial CT and fused PET/CT images before and after therapy. A 79-year-old male patient presented with history of left bronchogenic carcinoma histopathologically proven to be adenocarcinoma, under treatment and referred for PET/CT follow-up after 3 months, showing rather stationary appearance of the identified left lower lung lobe (apical segment) hypermetabolic heterogeneously enhancing infiltrative lesion (arrow), currently achieving minimal lesser activity 10.6 SUVmax (compared to 11.6 SUVmax previously), showing central photopenic zone of necrosis and invading the overlying pleural surfaces and chest wall with regional destruction of the overlying ribs. SUV average of the liver background measuring 2. e, f Whole body MIP before and after therapy showing stable metabolic response